Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Vagner

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Headache and Pain|April 18, 2023
PAR2 activation in the dura causes acute behavioral responses and priming to glyceryl trinitrate in a mouse migraine modelBianca N Mason, Shayne N Hassler, Kathryn DeFea, et al.
Biomedical Optics Express|July 23, 2016
Imaging of targeted lipid microbubbles to detect cancer cells using third harmonic generation microscopyKaitlin Harpel, Robert Dawson Baker, Babak Amirsolaimani, et al.
Scientific Reports|February 28, 2018
Targeting Ligand Specificity Linked to Tumor Tissue Topological Heterogeneity via Single-Cell Micro-Pharmacological ModelingAleksandra Karolak, Veronica C Estrella, Amanda S Huynh, et al.
The Journal of Biological Chemistry|April 7, 2011
The protease-activated receptor-2-specific agonists 2-aminothiazol-4-yl-LIGRL-NH2 and 6-aminonicotinyl-LIGRL-NH2 stimulate multiple signaling pathways to induce physiological responses in vitro and in vivoAndrea N Flynn, Dipti V Tillu, Marina N Asiedu, et al.
Cephalalgia : an International Journal of Headache|June 1, 2018
Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in miceShayne N Hassler, Fatima B Ahmad, Carolina C Burgos-Vega, et al.
Bioconjugate Chemistry|September 22, 2012
Lanthanide labeling of a potent protease activated receptor-2 agonist for time-resolved fluorescence analysisJustin Hoffman, Andrea N Flynn, Dipti V Tillu, et al.
Bioconjugate Chemistry|June 27, 2007
Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R)Heather L Handl, Rajesh Sankaranarayanan, Jatinder S Josan, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2007
Squalene-derived flexible linkers for bioactive peptidesBhumasamudram Jagadish, Rajesh Sankaranarayanan, Liping Xu, et al.
Journal of Medicinal Chemistry|October 27, 2012
Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapyAmanda Shanks Huynh, Woo Jin Chung, Hyun-Il Cho, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 15, 2011
Fluorescent and lanthanide labeling for ligand screens, assays, and imagingJatinder S Josan, Channa R De Silva, Byunghee Yoo, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Headache and Pain|April 18, 2023
PAR2 activation in the dura causes acute behavioral responses and priming to glyceryl trinitrate in a mouse migraine modelBianca N Mason, Shayne N Hassler, Kathryn DeFea, et al.
Biomedical Optics Express|July 23, 2016
Imaging of targeted lipid microbubbles to detect cancer cells using third harmonic generation microscopyKaitlin Harpel, Robert Dawson Baker, Babak Amirsolaimani, et al.
Scientific Reports|February 28, 2018
Targeting Ligand Specificity Linked to Tumor Tissue Topological Heterogeneity via Single-Cell Micro-Pharmacological ModelingAleksandra Karolak, Veronica C Estrella, Amanda S Huynh, et al.
The Journal of Biological Chemistry|April 7, 2011
The protease-activated receptor-2-specific agonists 2-aminothiazol-4-yl-LIGRL-NH2 and 6-aminonicotinyl-LIGRL-NH2 stimulate multiple signaling pathways to induce physiological responses in vitro and in vivoAndrea N Flynn, Dipti V Tillu, Marina N Asiedu, et al.
Cephalalgia : an International Journal of Headache|June 1, 2018
Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in miceShayne N Hassler, Fatima B Ahmad, Carolina C Burgos-Vega, et al.
Bioconjugate Chemistry|September 22, 2012
Lanthanide labeling of a potent protease activated receptor-2 agonist for time-resolved fluorescence analysisJustin Hoffman, Andrea N Flynn, Dipti V Tillu, et al.
Bioconjugate Chemistry|June 27, 2007
Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R)Heather L Handl, Rajesh Sankaranarayanan, Jatinder S Josan, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2007
Squalene-derived flexible linkers for bioactive peptidesBhumasamudram Jagadish, Rajesh Sankaranarayanan, Liping Xu, et al.
Journal of Medicinal Chemistry|October 27, 2012
Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapyAmanda Shanks Huynh, Woo Jin Chung, Hyun-Il Cho, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 15, 2011
Fluorescent and lanthanide labeling for ligand screens, assays, and imagingJatinder S Josan, Channa R De Silva, Byunghee Yoo, et al.
Pageof 8